DNTH
DNTH
US2528281080
Dianthus Therapeutics, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Market & Enterprise Value
Market Cap
4.5B EUR
5.34B EUR
4.58B EUR
Enterprise Value
3.73B EUR
5.23B EUR
3.95B EUR
Valuation Multiples
Trailing P/E
--
--
--
Forward P/E
-17.86x
--
--
Price to Sales
2,364.95x
2,805.54x
3,428.58x
Price to Book
3.85x
4.56x
3.81x
EV/Revenue
1,956.48x
2,748.15x
2,959.79x
EV/EBITDA
-17.11x
--
--
Price to FCF (P/FCF)
--
--
--
EV/FCF
--
--
--
FCF Yield
-2.05%
-2.91%
-2.85%
ende